Oral progestagens before menopause and breast cancer risk

We examined the relationship between use of progestagen-only before menopause (except for mini-pills) after the age of 40 and invasive breast cancer risk in 73 664 women from the French E3N cohort study (mean age at start of follow-up, 51.8 years; mean duration of follow-up, 9.1 years). A total of 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2007-03, Vol.96 (5), p.841-844
Hauptverfasser:	FABRE, A, FOURNIER, A, MESRINE, S, DESREUX, J, GOMPEL, A, BOUTRON-RUAULT, M.-C, CLAVEL-CHAPELON, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Breast cancer Breast Neoplasms - chemically induced Cancer Cohort Studies Epidemiology Female Gynecology and obstetrics Gynecology. Andrology. Obstetrics Human health and pathology Humans Life Sciences Mammary gland diseases Medical sciences Middle Aged Premenopause - drug effects Progestins - adverse effects Risk Factors Santé publique et épidémiologie Time Factors Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!